Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Sourij, H; Schmoelzer, I; de Campo, A; Tripolt, NJ; Stojakovic, T; Scharnagl, H; Kettler-Schmut, E; Forst, T; Wascher, TC.
Non-glycemic effects of insulin therapy: a comparison between insulin aspart and regular human insulin during two consecutive meals in patients with type 2 diabetes.
Eur J Endocrinol. 2011; 165(2): 269-274. Doi: 10.1530/EJE-11-0061 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Sourij Harald
Co-Autor*innen der Med Uni Graz
DeCampo Antonella
Kettler-Schmut Eva
Scharnagl Hubert
Stojakovic Tatjana
Tripolt Norbert
Wascher Thomas
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Objective: To control postprandial hyperglycemia in insulin-treated type 2 diabetic patients, prandial therapy with regular human insulin (HI) or fast acting insulin analogs is used. Postprandial hyperglycemia seems to be reduced more effectively with insulin analogs than with normal insulin, but there are no data concerning the effect on lipolysis or pancreatic insulin and proinsulin secretion of normal insulin in comparison to insulin analogs. Design and methods: We included 13 patients with type 2 diabetes mellitus (age 62.2 +/- 10.3 years) with preexisting insulin therapy in this crossover, prospective, open-labeled, randomized trial comparing regular HI with insulin aspart (IA) in the setting of a standardized breakfast and a standardized lunch 4 h later. Blood samples for determination of glucose, free fatty acids (FFA), triglycerides, C-peptide, and intact proinsulin were drawn during fasting and every 30 min until 4 h after the second test meal. Statistical analysis was performed with ANOVA for repeated measurements and paired Student's t-test. Results: The mean increase in blood glucose was significantly lower after IA (24.18 +/- 16.33 vs 34.92 +/- 29.07 mg/dl, P=0.02) compared with HI. Both therapies reduced FFA; however, the mean reduction was significantly higher after IA than after HI (-0.47 +/- 0.16 vs -0.35 +/- 0.15 mmol/l, P<0.001). The mean increase in intact proinsulin was significantly lower after IA than after HI (10.53 +/- 5 vs 15.20 +/- 6.83 pmol/l, P<0.001). No differences were observed in the C-peptide levels between the two groups. Conclusion: In the setting of two consecutive meals, IA reduces lipolysis and proinsulin secretion more effectively than HI.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Blood Glucose - drug effects
Cross-Over Studies -
Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy
Drug Administration Schedule -
Eating - drug effects Eating - physiology
Female -
Humans -
Hyperglycemia - blood Hyperglycemia - prevention and control
Hyperlipidemias - blood Hyperlipidemias - metabolism
Insulin - administration and dosage Insulin - analogs and derivatives Insulin - pharmacology
Male -
Middle Aged -
Postprandial Period - drug effects
Time Factors -

© Med Uni Graz Impressum